# Correlation of urine ammonia excretion with renal function in healthy dogs and dogs with chronic kidney disease

**Authors:** Autumn N Harris, Alexis Copper, Rebeca A Castro, Andrew J Specht, Allison R Kendall, Shelly L Vaden, Kirsten L Cooke

PMC · DOI: 10.1093/jvimsj/aalaf016 · Journal of Veterinary Internal Medicine · 2026-01-21

## TL;DR

This study shows that dogs with chronic kidney disease excrete less ammonia in their urine, which is linked to worse kidney function.

## Contribution

The study is the first to demonstrate a correlation between urine ammonia excretion and kidney function in dogs with CKD.

## Key findings

- Dogs with CKD had significantly lower urine ammonia-to-creatinine ratios than healthy dogs.
- Urine ammonia excretion was inversely correlated with serum creatinine levels, a marker of kidney function.
- The relationship between ammonia excretion and kidney function remained significant after adjusting for other variables.

## Abstract

Inadequate ammonia excretion is thought to drive the development of metabolic acidosis in people with chronic kidney disease (CKD) and correlates with worse clinical outcomes, such as faster progression to end-stage kidney disease and increased case fatality.

To determine if urine ammonia-to-creatinine ratio (UACR) correlates with serum creatinine concentration as a renal function marker in healthy dogs and dogs with CKD and whether UACR is altered in the presence of CKD.

The study group comprised 46 healthy and 50 stable International Renal Interest Society (IRIS) Stages 2, 3, and 4 CKD dogs.

This was a prospective, single–time point study. Serum biochemistry variables were measured. Urinary ammonia and creatinine concentrations were measured and used to calculate UACR. Group comparisons were made with the Mann–Whitney test. Correlation between UACR and serum renal and electrolyte values was assessed using Spearman’s correlation test. Relationships between UACR, renal variables, electrolytes, urine specific gravity, age, and body weight were explored with multiple linear regression.

CKD dogs had lower UACR (median 2.2; range 0.9-10.5) than healthy dogs (median 7.1; range 0.7-40.0) (P < .001). UACR was inversely correlated with creatinine concentrations (P < .001, rs = −0.535). The relationship between UACR and creatinine persisted after controlling for age, body weight, electrolytes, renal functional variables, and urine specific gravity.

These findings suggest that ammonia excretion is impaired in dogs with diminished renal function.

## Linked entities

- **Diseases:** chronic kidney disease (MONDO:0005300)

## Full-text entities

- **Diseases:** IRIS (MESH:C000719191), kidney disease (MESH:D007674), impaired cardiac function (MESH:D006331), death (MESH:D003643), mineral and bone disorders (MESH:D012080), end-stage kidney disease (MESH:D007676), urinary tract infection (MESH:D014552), gastrointestinal alkali loss (MESH:D006934), Acidosis (MESH:D000138), tubulointerstitial injury (MESH:D009395), azotemia (MESH:D053099), proteinuria (MESH:D011507), inflammation (MESH:D007249), tubular dysfunction (MESH:D005198), nephron loss (MESH:D007683), diminished renal function (MESH:D015354), bacteriuria (MESH:D001437), CKD (MESH:D051436)
- **Chemicals:** capromorelin (MESH:C433143), glutamine (MESH:D005973), maropitant citrate (MESH:C518176), selegiline (MESH:D012642), alkali (MESH:D000468), aluminum hydroxide (MESH:D000536), gabapentin (MESH:D000077206), amlodipine (MESH:D017311), hydrogen (MESH:D006859), tramadol (MESH:D014147), ondansetron (MESH:D017294), Creatinine (MESH:D003404), calcium (MESH:D002118), Ammonia Reagent (-), clopidogrel (MESH:D000077144), K (MESH:D011188), Na+ (MESH:D012964), omeprazole (MESH:D009853), mirtazapine (MESH:D000078785), Cl- (MESH:D002713), HCO3- (MESH:D001639), cisapride (MESH:D020117), polysulfated glycosaminoglycan (MESH:C013786), famotidine (MESH:D015738), enalapril (MESH:D004656), Chloride (MESH:D002712), tamsulosin (MESH:D000077409), phosphate (MESH:D010710), acid (MESH:D000143), pimobendan (MESH:C041648), Ammonia (MESH:D000641), ammonium (MESH:D064751), mineral oil (MESH:D008899), symmetric dimethylarginine (MESH:C024917), phenylpropanolamine (MESH:D010665), telmisartan (MESH:D000077333), carprofen (MESH:C007005)
- **Species:** Homo sapiens (human, species) [taxon 9606], Felis catus (cat, species) [taxon 9685], Canis lupus familiaris (dog, subspecies) [taxon 9615]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12881969/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12881969/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12881969/full.md

---
Source: https://tomesphere.com/paper/PMC12881969